Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
April 2014

Recent Stories of Interest

From Specialty Pharmacy News - Although site-of-care optimization is certainly not a new approach to help control the costs of specialty drugs, health plans generally have applied the tactic to oncology therapies. But that will change on April 1, when Highmark Inc. will attempt to counter rising costs of oncology care services by eliminating markups. The Blues plan says it expects the billing change will save more than $200 million annually — and will not impact the quality of care members receive. Read more

With supermarkets’ interest in the specialty pharmacy space showing no signs of… Read more

With the growth of oral multiple sclerosis (MS) therapies booming and the… Read more

About one month after agreeing to a $15 million settlement with the… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

April 23, 2014
FDA Approves Lilly Stomach Cancer Drug

FDA approves Eli Lilly’s Cyramza (ramucirumab) to treat advanced gastric cancer after prior chemo; the FDA gave the injectable orphan drug status and approved it under its priority review program

April 22, 2014
GlaxoSmithKline Deal With Novartis Includes Building Up OTC Business While Divesting Oncology Portfolio

New GlaxoSmithKline three-part deal with Novartis includes building up OTC business while divesting oncology portfolio.

April 21, 2014
Express Scripts Is Awarded New DOD Contract

Express Scripts continues long-standing Dept. of Defense relationship with new seven-year deal.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?